In a G-protein-coupled receptor (GPCR) pathway, a ligand binds to the receptor and activates a G protein, which then activates adenylyl cyclase. What is the most likely direct role of cyclic AMP (cAMP) in this pathway?

Core Concept

PILLAR 1 — MOLECULAR/CONCEPTUAL MECHANISM

Step-by-Step Analysis

Cyclic AMP (cAMP) is synthesized when adenylyl cyclase, a transmembrane enzyme anchored in the plasma membrane, catalyzes the cyclization of ATP by cleaving two phosphate groups and forming a covalent phosphodiester bond between the 3′ and 5′ carbon atoms of the ribose sugar. This compact, ring-shaped molecule persists until phosphodiesterase hydrolyzes it back into ordinary AMP. Because cAMP is water-soluble and small, it diffuses rapidly through the cytosol, but it cannot cross the hydrophobic core of the phospholipid bilayer without a dedicated transporter, so its concentration is compartmentally regulated within the cell.

Why Other Options Are Wrong

The direct molecular target of cAMP is Protein Kinase A (PKA), a holoenzyme composed of two regulatory (R) subunits and two catalytic (C) subunits. In its inactive state, the R subunits bind the C subunits and mask their active sites through steric occlusion. Each R subunit contains two tandem cyclic-nucleotide-binding domains (CNB-A and CNB-B) with conserved arginine and glutamate residues that form hydrogen bonds and electrostatic contacts with the phosphate-bearing ring of cAMP. When four molecules of cAMP bind cooperatively—two per R subunit—conformational strain forces the R subunits to undergo a large-scale structural rearrangement, dissociating from the C subunits. The liberated C subunits now expose their ATP-binding active site and their substrate-recognition groove, enabling them to phosphorylate serine and threonine residues on dozens of downstream effector proteins. These targets include phosphorylase kinase (which mobilizes glycogen breakdown), CREB (a transcription factor that alters gene expression), and various ion-channel proteins that shift membrane potential.

PILLAR 2 — STEP-BY-STEP LOGIC

Tracing the pathway from ligand binding clarifies why cAMP's most likely direct role is that of a second messenger activating PKA rather than performing any enzymatic or receptor-binding function itself. First, an extracellular primary messenger—epinephrine, for example—binds the orthosteric site on the seven-transmembrane-helix GPCR. Ligand occupancy forces transmembrane helix 6 to rotate outward, exposing a binding cleft on the receptor's intracellular face. An inactive, GDP-bound heterotrimeric G protein (Gαβγ) docks onto this cleft; contact triggers the Gα subunit to release GDP and capture GTP. GTP binding causes switch I and switch II regions of Gα to refold, weakening its affinity for the Gβγ dimer and for the receptor. The dissociated, GTP-loaded Gα diffuses laterally in the inner leaflet until it contacts adenylyl cyclase. Gα binding to adenylyl cyclase stabilizes the enzyme's catalytic domain in a conformation that accommodates ATP and drives cyclization. The product, cAMP, accumulates in the cytosol and, as detailed above, directly binds PKA regulatory subunits. Therefore, the direct, immediate molecular function of cAMP in this cascade is to serve as an intracellular second messenger that activates protein kinase A, which then relays the signal through phosphorylation of downstream targets. No step in this mechanism involves cAMP acting as an enzyme, a GPCR ligand, a transcription factor, or a G-protein activator.

PILLAR 3 — DISTRACTOR ANALYSIS

Option A suggests cAMP directly phosphorylates target proteins. This misattribute confuses the second messenger with the kinase it activates; only enzymes like PKA possess catalytic domains with the ATP-transfer chemistry needed for phosphoryl group transfer. Students selecting A overlook the structural requirement of a kinase active site.

Option C claims cAMP binds the GPCR to amplify the signal. This reverses the flow of information: GPCR activation precedes and causes cAMP production, not the reverse. The distractor exploits confusion about positive-feedback loops, but feedback requires downstream signals acting on upstream components—cAMP has no known binding pocket on any GPCR.

Option D states cAMP deactivates the G protein by hydrolyzing GTP. GTP hydrolysis is an intrinsic property of the Gα subunit, accelerated by RGS (Regulator of G-protein Signaling) proteins, not by cAMP. This option traps students who conflate signal termination mechanisms across different pathway stages.

Option E proposes cAMP enters the nucleus and functions as a transcription factor. While PKA can phosphorylate CREB, which then enters the nucleus, cAMP itself lacks a DNA-binding domain and cannot directly interact with promoter elements. This option tempts students who recognize that the pathway ultimately alters gene expression but fail to distinguish direct from indirect effects.